Hospital Álvaro Cunqueiro
11
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis
Role: collaborator
Wearable Technology in the Detection and Evaluation of Sleep-Related Breathing Disorders
Role: collaborator
Transcatheter Mitral and Tricuspid Interventions: a Cardiac Magnetic Resonance Study
Role: collaborator
Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral
Role: collaborator
Comparative Assessment of Effectiveness and Safety of L-ESPB Versus Absence of Locoregional Block in Hip Surgery
Role: lead
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
Role: collaborator
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
Role: collaborator
Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis
Role: collaborator
Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area
Role: lead
Registry of Acute Coronary Syndrome From University Hospital of Vigo
Role: lead
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Role: collaborator
All 11 trials loaded